If you're dealing with hard PMS, anxiety, or cycles that just feel off, it's natural to wonder about progesterone. Progesterone deficiency, sometimes called luteal phase deficiency (LPD), gets a lot of attention online. The research is more careful. LPD has been described in fertile, normally menstruating women, and it has not been proven to be a separate condition causing infertility or recurrent pregnancy loss (ASRM Practice Committee, 2026). In a study of regularly menstruating women, about 9% of ovulatory cycles had a short luteal phase and about 8% had low luteal progesterone (Schliep et al., 2014).
What Is Progesterone and Why Does It Matter?
Progesterone is a steroid hormone made mainly by the corpus luteum in the ovary after ovulation (Barbieri, 2014). It plays a part in:
- Preparing the uterine lining for potential implantation of a fertilized egg (Barbieri, 2014)
- Supporting early pregnancy until the placenta takes over production (Saccone et al., 2026)
- Acting on the brain through its metabolite allopregnanolone, which acts on GABA-A receptors (Bixo et al., 2026)
- Working with estrogen to change the uterine lining during the cycle (Barbieri, 2014)
When ovulation stops for a long time, the uterine lining can get long-term estrogen stimulation without progesterone. This can bring irregular bleeding and raise the risk of endometrial cancer (Sweet et al., 2012). You may see the term "estrogen dominance" used online for a wide range of symptoms. It isn't an established medical diagnosis.
Signs and Symptoms of Low Progesterone
Many symptoms get linked to low progesterone, but the evidence differs for each one:
- Severe PMS or PMDD: Mood swings, irritability and depression in the luteal phase. Research found that symptoms can be an abnormal response to normal hormone changes, not a matter of low levels (Schmidt et al., 1998) (Wei et al., 2025). One small study did find lower progesterone in women with PMS (Monteleone et al., 2000)
- Anxiety and restlessness: Allopregnanolone can be sedating at high levels, and in a minor share of people it can cause anxiety and irritability at lower levels (Bixo et al., 2026)
- Disrupted sleep: Poorer sleep around your period can happen in women with premenstrual symptoms or painful cramps (Alzueta et al., 2023)
- Short luteal phase: Cycles where your period arrives 10 days or fewer after ovulation (ASRM Practice Committee, 2026)
- Heavy or irregular periods: Not ovulating can bring irregular bleeding (Sweet et al., 2012). See a clinician for heavy bleeding or any bleeding that's new for you
- Recurrent early miscarriage: Low progesterone in early pregnancy can be a marker of a pregnancy that isn't viable, and not the cause of the loss (Saccone et al., 2026)
Luteal Phase Deficiency: The Clinical Picture
LPD is a clinical diagnosis tied to a luteal phase of 10 days or fewer. Possible causes include too little progesterone, too short a time with it, or a uterine lining that responds poorly to it (ASRM Practice Committee, 2026). Low progesterone or a missed ovulation can happen with:
- Anovulatory cycles: If you do not ovulate, no corpus luteum forms to make progesterone (Barbieri, 2014)
- Stress: In a study of 259 healthy women, high daily stress was linked with lower luteal progesterone and higher odds of anovulation (Schliep et al., 2015). You may read about "pregnenolone steal" as the reason, but that idea isn't established
- Thyroid dysfunction: Both underactive and overactive thyroid can cause menstrual disturbances (Krassas et al., 2010)
- PCOS: One of the causes of chronic anovulation (Sweet et al., 2012)
- Perimenopause: Ovulation and progesterone can become insufficient or absent (Prior, 2011)
- Excessive exercise or undereating: Weight loss and excessive exercise can go with functional hypothalamic amenorrhea, a form of chronic anovulation (Gordon et al., 2017)
The Anxiety and Progesterone Connection
Progesterone has effects on the brain. It is converted to allopregnanolone, a neurosteroid that acts on the GABA-A receptor, the same receptor targeted by anti-anxiety medications like benzodiazepines. But the link to mood isn't as simple as low levels causing anxiety, as the symptoms section above explains.
A 2014 review published in Psychopharmacology concluded that allopregnanolone may trigger mood symptoms in susceptible women, though baseline levels may not reliably distinguish women with premenstrual dysphoria from those without (Schiller et al., 2014).
If you have ongoing anxiety, panic or low mood, talk to a clinician, and don't wait on a hormone test to get help. If you have thoughts of harming yourself, seek help right away.
Progesterone, Sleep, and Insomnia
Progesterone's effect on sleep is less clear than you may have read. In regular cycles without symptoms, objective sleep continuity stays about the same across the cycle, though sleep spindle activity can rise in the luteal phase, when progesterone is present (Alzueta et al., 2023). Ongoing insomnia is worth raising with a clinician at any point in your cycle.
Miscarriage Risk
Progesterone is essential for maintaining pregnancy. A 2015 randomized trial in the New England Journal of Medicine found that first-trimester progesterone did not significantly raise live birth rates in women with unexplained recurrent miscarriage (Coomarasamy et al., 2015). A 2026 review found no significant overall benefit across trials, with a possible advantage in women with both early bleeding and prior miscarriages (Saccone et al., 2026). If you've had recurrent losses, a specialist can talk through which tests and treatments fit, since a European guideline also lists some that should not be used (Bender Atik et al., 2023). If you're pregnant and taking progesterone, talk to your clinician before changing anything.
How to Test Progesterone: The Day 21 Test
Timing matters for this test. Cycle day, time of day and pulses of release can significantly alter a single progesterone level (Fujimoto et al., 1990).
A common test is a mid-luteal blood draw - around day 21 of a 28-day cycle, when progesterone production is at its peak (Barbieri, 2014). Day 21 doesn't fit every cycle. In one study, ovulation ranged from day 8 to day 26 (Roos et al., 2015), and a reference study set the mid-luteal phase at 5 to 9 days after the LH peak (Stricker et al., 2006). One research team concluded that confirming ovulation along with a well-timed progesterone level may be a useful way to assess LPD (Schliep et al., 2014).
What the Numbers Can and Can't Tell You
There's no single agreed cutoff. Studies have used different numbers, and these can't be read as targets:
- 5 ng/mL or less: one study's definition of low luteal progesterone (Schliep et al., 2014)
- Below 10 ng/mL: a 1994 study's recommended test for low progesterone across the luteal phase, from a single mid-luteal level (Jordan et al., 1994)
- 9.4 ng/mL: the lower limit one older fertility study suggested for a potentially fertile cycle (Hull et al., 1982)
These are research cutoffs, not treatment goals. Levels can vary widely between cycles in the same woman (Stricker et al., 2006), and controversy remains over how to diagnose LPD and whether treating it improves outcomes (ASRM Practice Committee, 2026). Your lab report lists its own ranges, so ask your clinician how to read your result.
Lab Tests That Can Help
Testing depends on your symptoms and goals. If your cycles are irregular or you may not be ovulating, a clinician may look for a cause. Anovulation can come from PCOS, uncontrolled diabetes, thyroid problems or high prolactin (Sweet et al., 2012). Tests may include:
- Progesterone (mid-luteal, timed to your own cycle)
- Thyroid tests such as TSH
- Prolactin
- Blood sugar tests
- Tests for PCOS if your symptoms fit (Teede et al., 2023)
What You Can Do
What helps depends on the cause, so this is a conversation to have with your clinician:
- Look for a cause: Thyroid problems and PCOS each have their own care
- Talk about stress and food: High daily stress and energy deficits can each go with missed ovulation (Schliep et al., 2015) (Gordon et al., 2017)
- Ask about treatment: Whether treating LPD improves outcomes isn't settled (ASRM Practice Committee, 2026). For severe PMS, research supports treatments such as serotonin reuptake inhibitors and approaches that stop ovarian cycling (Yonkers et al., 2008)
- Track your cycle: Ovulation predictor kits can help, since the start of the LH surge was an excellent predictor of ovulation in one study (Roos et al., 2015). Basal body temperature can help less, since it was unreliable for precise timing (de Mouzon et al., 1984)
References
- Prior, J. C. (2011). Progesterone for symptomatic perimenopause treatment - progesterone politics, physiology, and potential for perimenopause. Facts, Views & Vision in ObGyn, 3(2), 109-120. PMID 24753856
- Schiller, C. E., et al. (2014). Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology, 231(17), 3557-3567. PMID 24846476
- Coomarasamy, A., et al. (2015). A randomized trial of progesterone in women with recurrent miscarriages. New England Journal of Medicine, 373(22), 2141-2148. PMID 26605928
- Barbieri, R. L. (2014). The endocrinology of the menstrual cycle. Methods in Molecular Biology, 1154, 145-169. PMID 24782009
- Monteleone, P., et al. (2000). Allopregnanolone concentrations and premenstrual syndrome. European Journal of Endocrinology, 142(3), 269-273. PMID 10700721
- Practice Committee of the American Society for Reproductive Medicine. (2026). Diagnosis and treatment of luteal phase deficiency: a Committee Opinion. Fertility and Sterility, 126(4), 633-639. PMID 42414147
- Schliep, K. C., et al. (2014). Luteal phase deficiency in regularly menstruating women: prevalence and overlap in identification based on clinical and biochemical diagnostic criteria. Journal of Clinical Endocrinology & Metabolism, 99(6), E1007-14. PMID 24606080
- Sweet, M. G., et al. (2012). Evaluation and management of abnormal uterine bleeding in premenopausal women. American Family Physician, 85(1), 35-43. PMID 22230306
- Schmidt, P. J., et al. (1998). Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. New England Journal of Medicine, 338(4), 209-216. PMID 9435325
- Wei, S. M., et al. (2025). Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings. American Journal of Psychiatry, 182(10), 922-934. PMID 41030005
- Bixo, M., et al. (2026). Neurosteroids and premenstrual dysphoric disorder. British Journal of Psychiatry, 229(1), 92-100. PMID 40518728
- Alzueta, E., et al. (2023). The Menstrual Cycle and Sleep. Sleep Medicine Clinics, 18(4), 399-413. PMID 38501513
- Saccone, G., et al. (2026). Progestogen supplementation to prevent miscarriage: Evidence and controversies. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics, 174(1), 44-49. PMID 41498246
- Schliep, K. C., et al. (2015). Perceived stress, reproductive hormones, and ovulatory function: a prospective cohort study. Epidemiology, 26(2), 177-184. PMID 25643098
- Krassas, G. E., et al. (2010). Thyroid function and human reproductive health. Endocrine Reviews, 31(5), 702-755. PMID 20573783
- Gordon, C. M., et al. (2017). Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 102(5), 1413-1439. PMID 28368518
- Bender Atik, R., et al. (2023). ESHRE guideline: recurrent pregnancy loss: an update in 2022. Human Reproduction Open, 2023(1), hoad002. PMID 36873081
- Fujimoto, V. Y., et al. (1990). Variability of serum prolactin and progesterone levels in normal women: the relevance of single hormone measurements in the clinical setting. Obstetrics and Gynecology, 76(1), 71-78. PMID 2359568
- Roos, J., et al. (2015). Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation. European Journal of Contraception and Reproductive Health Care, 20(6), 438-450. PMID 26018113
- Stricker, R., et al. (2006). Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT analyzer. Clinical Chemistry and Laboratory Medicine, 44(7), 883-887. PMID 16776638
- Jordan, J., et al. (1994). Luteal phase defect: the sensitivity and specificity of diagnostic methods in common clinical use. Fertility and Sterility, 62(1), 54-62. PMID 8005304
- Hull, M. G., et al. (1982). The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ("ovulation") derived form treated and untreated conception cycles. Fertility and Sterility, 37(3), 355-360. PMID 7060786
- Teede, H. J., et al. (2023). Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Journal of Clinical Endocrinology & Metabolism, 108(10), 2447-2469. PMID 37580314
- Yonkers, K. A., et al. (2008). Premenstrual syndrome. Lancet, 371(9619), 1200-1210. PMID 18395582
- de Mouzon, J., et al. (1984). Time relationships between basal body temperature and ovulation or plasma progestins. Fertility and Sterility, 41(2), 254-259. PMID 6421622



